Application Notes | The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. |
Application References | 1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) 2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) 3. Suzuki K, et al. 2000. Immunity 13:691. (IHC) 4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP) 5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837. 6. Pascal V, et al. 2007. J. Immunol. 179:1751. 7. Burman AC, et al. 2007. Blood 110:1064. 8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187. 9. Phan TG, et al. 2007. Nature Immunol. 8:992. 10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed " |
Description | CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1. |